This article was originally published in The Tan Sheet
Novartis OTC plant not “out of the woods”; ERSP questions Calmestra claims; GSK seeks to switch Pirinase Hayfever Relief to GSL in U.K.; Kaneka raises CoQ10 prices; FTC to disburse consumer refund for Iovate supplements; more In brief.
You may also be interested in...
Novartis narrows consumer decline in Q4; Abbott sanguine on China market; FDA warns Food for Health International; Suspect studies taint Bio-Strath claims, NAD says; NACDS debuts Total Store Expo; more news In Brief.
Robinson steps up to drug production; no warning needed for St. John’s wort, CRN says; Iovate settles with Calif. counties; more In Brief